Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioregenx (BRGX) Return on Capital Employed (2023 - 2025)

Bioregenx (BRGX) has 3 years of Return on Capital Employed data on record, last reported at 6.71% in Q3 2025.

  • For Q3 2025, Return on Capital Employed rose 704.0% year-over-year to 6.71%; the TTM value through Sep 2025 reached 6.71%, up 704.0%, while the annual FY2024 figure was 7.73%, 626.0% up from the prior year.
  • Return on Capital Employed reached 6.71% in Q3 2025 per BRGX's latest filing, up from 6.09% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 17.72% in Q3 2023 and bottomed at 18.42% in Q2 2023.
  • Average Return on Capital Employed over 3 years is 0.54%, with a median of 0.33% recorded in 2024.
  • The widest YoY moves for Return on Capital Employed: up 1796bps in 2024, down -1805bps in 2024.
  • A 3-year view of Return on Capital Employed shows it stood at 1.46% in 2023, then crashed by -394bps to 4.29% in 2024, then soared by 256bps to 6.71% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 6.71% in Q3 2025, 6.09% in Q2 2025, and 6.04% in Q1 2025.